FDA Investigator James A Liubicich

James A Liubicich has conducted inspections on 162 sites in 7 countries as of 07 Jan 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
162
Last Inspection Date:
07 Jan 2016
Investigator Role:
FDA Investigator
Redica ID:
100005763
Countries of Inspections:
United States of America, Germany, Canada, France, Italy, United Kingdom of Great Britain and Northern Ireland, Switzerland
FDA Investigators that have inspected at least one site in common with James A Liubicich:
Adena S Yau, Adetutu M Gidado, Alia Legaux, Alice S Tsao, Althea A Williams, Amatul H Marium, Amy Wyan Mai, Andrew B Paglia, DPM, Andrew Byro, Andrew M Abramowitz, Angela E Glenn, Anissa M Vargas, Anita R Michael, Ann M Stewart, Anna Lazar, Anne Marie Dubrey, Arduino Frankovic, Armia A Beshay, Arthur G Hurst, Atul J Agrawal, Avital A Shimanovich, Aziz A Mamur, Azza Talaat, Barbara Jwilimczyk Macri, Benton M Ketron, Betty M Ng Lee, Bijoy Panicker, Brandy N Lepage, Carl A Huffman, III, Carrie E Jolly, CDR Thomas R Berry, PPh, Charanjeet Jassal, Charisse K Green, Charles M Edwards, Christian Parra, Christine M Rivera, Christopher S Fields, Clinton J Lott, Crystal Monroy, Dale A Nyberg, Daniel J Grabicki, Daniel L Zheng, Danna E Solorzano, Daryl A Dewoskin, David M Beltran, David R Delucia, Deborah J Parris, Demitria J Argiropoulos, Demitria J Xiradakis, Denise L Terzian, Denise M Digiulio, Dennis E Guilfoyle, PhD, Deyaa Shaheen, Dilijeta Bajrami, Dipesh K Shah, Donald G Gordon, Dongping Dai, PhD, Douglas G Ng, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edouard Viard, Erica B Brush, Erica B Raphael, Evan Tong, Felix Maldonado, Frank Verni, Gam S Zamil, Ganesh N Joshi, Gary J Lehr, Gary T Greco, Gloria E Parra, Guerlain Ulysse, Helen B Ricalde, Henry E Sanchez, Huascar Batista, Ilana Zigelman, Iram R Hassan, PhD, Irina Gaberman, J'maica J Hunter, Jackson Y See, Jacqueline S Warner, Jagdish R Amin, Jaison J Eapen, Jane C Chen, Janet L Bowen, Jason D Tenney, Javier O Vega, Jawaid Hamid, Jay T Wong, Jazmine N Brown, Jazmine N Still, John A Gonzalez, John A Podsadowski, Johnna L Bleem, Jose A Lopez, Jose Acruz Gonzalez, Jose M Cayuela, Jose Ohernandez Guzman, Joseph J Vannelli, Joseph Maselli, Joshua S Hunt, Joy P Matthias, Juan Rjimenez Garcia, Juanita P Versace, Justin A Boyd, Justine Tomasso, Kara D Dobbin, Karen A Briggs, Karen L Kosar, Karishma G Gopaul, Karl Auguste, Katherine Szestypalow, Kathleen D Culver, Kelli F Dobilas, Kenneth G Klobus, Kenneth H Williams, Kenneth M Gordon, Kerry D Noto, Kevin A Gonzalez, Kevin J Flessa, Kim Lthomas Cruse, Kimberley A Ricketts, Kimberly Y Smithson, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Latorie S Jones, Laura M Howard, Lawrence W Farina, LCDR Chad N Thompson, LCDR Michael H Tollon, Leena Thomas, Lisa Mathew, Lynnette I Riggio, Manhar R Patel, Marea K Harmon, Margaret E Sarles, Margaret M Sands, Marianna Viner, Marie A Fadden, Marie B Buen Bigornia, Mark E Parmon, Matthew A Spataro, Matthew B Casale, Melissa J Garcia, Meredith L Sheridan, Meredith P Soehl, Investigator, Michael A Charles, Michael Levin, Michael R Dominick, Michele L Obert, Milva E Melendez Perales, Mina D Ahmadi, Mindy M Chou, Miral B Patel, Mra Davism, Muralidhara B Gavini, PhD, Nancy A Saxenian Emmons, Nariman Patenaude, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas A Violand, Omadevi Somai, Investigator, Paraluman S Leonin, Parul M Patel, Patrick C Klotzbuecher, Paul E Stein, Paul L Bellamy, Paul Mouris, Perry T Nichols, Peter Abel, Peter C Chow, Peter Caparelli, Peter M Trunk, Peter R Caparelli, Peter S Diak, Philip F Istafanos, DMV, MS, Phyllis J Wilson, Rachael A Moliver, Rachael O Oyewole, Raihan A Chowdhury, Rajiv R Srivastava, Ramon A Hernandez, Reba A Gates, Regina T Brown, Richard Ferfoglia, Robert C Howard, Robert C Steyert, Robert D Tollefsen, Robert J Veitch, Rochelle K Kimmel, Ronald Ifraimov, Rose Xu, Russell J Glapion, Samina S Khan, Samuel K Mathew, Samuel T Walker, Sarah A Meehan, Sarah A Wangseng, Sarah Adella Fave, Sarah E Mcmullen, Satheesh Thomas, Shantelle I Hughes, Shari L Kahn, Shelby N Turner, Shreya Shah, Simone E Pitts, Sixto M Mercado Rios, Sony Mathews, Sripal R Mada, PhD, Stacey S Degarmo, Steven A Gonzales, Steven M Weinman, Sung K Kim, Susan M Jackson, Susan M Joseph, Susan T Hadman, Susan W Ting, Suwaskie S Smith, Syeda N Mahazabin, Tanya R Syffrard, Tara K Carmody, Tara K Normandin, Tekalign Wondimu, Terry Bridgewater, Thomas E Friel, Thomas J Arista, Thomas J Mooney, Thomas P Hansen, Thomas W Gordon, Thomas W Nojek, Tracey L Harris, Tracy M Portelli, Travis R Hunt, Uduak M Inokon, Valentino Fiorella, Valerie A Potopsingh, Vanessa M Williams, Verlinda A Narcisse, Victoria A Wagoner, Vivin George, Wayne S Fortenberry, William J Leonard, Winston R Alejo, Xiaoping Guan, Yasamin Ameri, Yumi J Hiramine, Yuyan Liang, Yvesna C Blaise

James A Liubicich's Documents

Publish Date Document Type Title
January, 2003 FDA 483 Response Epic Pharma, LLC - Form 483R, 2003-01-28
February, 2005 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2005-02-04
January, 2002 FDA 483 Lawrence Hospital - Form 483, 2002-01-29
October, 2002 EIR Carbogen-Amcis AG - EIR, 2002-10-09
March, 2010 FDA 483 Pharbest Pharmaceuticals, Inc. - Form 483, 2010-03-30
January, 2003 EIR Epic Pharma, LLC - EIR, 2003-01-16
August, 2000 EIR Perrigo New York, Inc. - EIR, 2000-08-10
June, 2013 FDA 483 Americare Compounding, LLC. - Form 483, 2013-06-19
February, 2012 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2012-02-01
July, 2014 FDA 483 Alexander Infusion LLC D/B/A Avanti Health Care - Form 483, 2014-07-09
November, 2012 EIR Epic Pharma, LLC - EIR, 2012-11-01
August, 2000 FDA 483 Perrigo New York, Inc. - Form 483, 2000-08-10
August, 2001 EIR Sanofi-Aventis U.S. LLC - EIR, 2001-08-07
March, 2007 EIR American Regent, Inc. - EIR, 2007-03-28
March, 2014 FDA 483 Kings Park Slope Inc - Form 483, 2014-03-14
February, 2005 FDA 483 Response Syntho Pharmaceuticals Inc. - Form 483R, 2005-02-23
June, 2009 FDA 483 TIME CAP LABORATORIES, INC - Form 483, 2009-06-29
February, 2000 FDA 483 Response Chartwell Pharmaceuticals Amityville, LLC. - Form 483R, 2000-03-01
April, 2003 EIR Pfizer, Inc. - EIR, 2003-04-10
February, 2006 EIR LNK International, Inc. - EIR, 2006-08-30
February, 2009 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2009-02-03
May, 2000 FDA 483 Response CORDEN PHARMA CHENÔVE - Form 483R, 2000-05-23
February, 2000 EIR Chartwell Pharmaceuticals Amityville, LLC. - EIR, 2000-02-18
September, 2002 EIR Pfizer, Inc. - EIR, 2002-09-27
October, 2015 FDA 483 Pine Pharmaceuticals, LLC - Form 483, 2015-10-09
October, 2000 FDA 483 Sciarra Laboratories Inc - Form 483, 2000-10-05
October, 2002 FDA 483 Response Cu Chemie Uetikon GmbH - Form 483R, 2002-12-04
October, 2002 FDA 483 Response Carbogen-Amcis AG - Form 483R, 2002-11-15
December, 2012 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2012-12-13
October, 2003 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2003-10-17
February, 2001 FDA 483 Response Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. - Form 483R, 2001-02-21
November, 2003 EIR Patheon Inc. - EIR, 2003-11-14
October, 2014 EIR Pine Pharmaceuticals, LLC - EIR, 2014-10-17
June, 2009 EIR TIME CAP LABORATORIES, INC - EIR, 2009-06-29
October, 2000 FDA 483 Response Sciarra Laboratories, Inc. - Form 483R, 2000-10-17
May, 2013 FDA 483 Allegiant Health - Form 483, 2013-05-16
May, 2015 FDA 483 MasterPharm LLC - Form 483, 2015-05-06
August, 2011 EIR P & L Development, LLC - EIR, 2011-08-10
June, 2015 FDA 483 Americare Compounding, LLC. - Form 483, 2015-06-22
February, 2001 FDA 483 Wyeth-Ayerst Pharmaceuticals - Form 483, 2001-02-01
October, 2002 EIR Cu Chemie Uetikon GmbH - EIR, 2002-10-17
April, 2013 FDA 483 Med Prep Consulting, Inc. - Form 483, 2013-04-03
July, 2007 FDA 483 Altaire Pharmaceuticals Inc. - Form 483, 2007-07-10
December, 2001 FDA 483 Response Nuvo Pharmaceuticals Inc. - Form 483R, 2002-02-04
December, 2001 EIR Nuvo Pharmaceuticals Inc. - EIR, 2001-12-13
May, 2012 EIR Barr Laboratories Inc. - EIR, 2012-05-03
October, 2007 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2007-10-03
May, 2000 FDA 483 CORDEN PHARMA CHENÔVE - Form 483, 2000-05-04
May, 2009 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2009-05-06
March, 2007 FDA 483 American Regent, Inc. - Form 483, 2007-03-28
April, 2014 FDA 483 Infusion Options, Inc. - Form 483, 2014-04-23
January, 2003 FDA 483 Epic Pharma, LLC - Form 483, 2003-01-16
December, 2013 FDA 483 Pine Pharmacy and Home Care Products Center, Inc. - Form 483, 2013-12-16
May, 2000 EIR CORDEN PHARMA CHENÔVE - EIR, 2000-05-04
April, 2003 FDA 483 Del Laboratories Inc. - Form 483, 2003-04-23
October, 2000 EIR Sciarra Laboratories, Inc. - EIR, 2000-10-05
January, 2008 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2008-01-30
December, 2008 EIR TIME CAP LABORATORIES, INC - EIR, 2008-12-05
December, 2001 EIR Vetoquinol N.-A. INC - EIR, 2001-12-06
August, 2001 FDA 483 Sanofi-Aventis U.S. LLC - Form 483, 2001-08-07
September, 2014 FDA 483 BioScrip Infusion Services of NY - Form 483, 2014-09-19
November, 2006 FDA 483 Geri-Care Pharmaceuticals, Corp - Form 483, 2006-11-22
March, 2008 FDA 483 Tri State Surgical - Form 483, 2008-03-20
February, 2006 EIR LNK International, Inc. - EIR, 2006-02-16
July, 2013 FDA 483 Pine Pharmacy and Home Care Products Center, Inc. - Form 483, 2013-07-19
December, 2008 FDA 483 TIME CAP LABORATORIES, INC - Form 483, 2008-12-05
March, 2015 FDA 483 Fallon Wellness Pharmacy, L.L.C. - Form 483, 2015-03-10
February, 2011 FDA 483 TIME CAP LABORATORIES, INC - Form 483, 2011-02-17
November, 2013 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2013-11-21
January, 2007 EIR Rochem International, Inc. - EIR, 2007-01-10
November, 2003 FDA 483 Patheon Inc. - Form 483, 2003-11-14
May, 2011 FDA 483 The Estee Lauder Inc - Form 483, 2011-05-25
April, 2003 FDA 483 Response Del Laboratories Inc. - Form 483R, 2003-05-20
February, 2006 FDA 483 LNK International, Inc. - Form 483, 2006-02-16
November, 2011 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2011-11-28
December, 2009 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2009-12-03
February, 2000 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2000-02-18
March, 2000 EIR Chartwell Pharmaceuticals Amityville, LLC. - EIR, 2000-03-15
January, 2002 FDA 483 Response Lawrence Hospital IRB - Form 483R, 2002-02-05
June, 2002 FDA 483 Sigma-Aldrich Company Ltd. - Form 483, 2002-06-20
November, 2003 FDA 483 Response Patheon Inc. - Form 483R, 2003-12-05
August, 2000 FDA 483 Response Perrigo New York, Inc. - Form 483R, 2000-09-21
January, 2002 EIR Lawrence Hospital IRB - EIR, 2002-01-29
February, 2013 FDA 483 Hikma Injectables USA Inc. - Form 483, 2013-02-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more